An Open Label, Prospective, One Arm, Feasibility, Study for The Use of Halevy Kit for the Treatment of Perianal Fistulas in Patients With Crohn's Disease
NCT ID: NCT00653094
Last Updated: 2008-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
10 participants
INTERVENTIONAL
2008-06-30
2009-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Halevy kit
the use of Halevy kit in Crohn patients with Fistulas
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Halevy kit
the use of Halevy kit in Crohn patients with Fistulas
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients suffering from Crohn's disease
* Patients with any number of simple or complex fistulas who require surgical intervention, requiring the insertion of a drain (Seton) into the fistula tract, and/or injection of biologic adhesive, or an anal fistula plug
* Able and willing to sign an informed consent
* Patient will be available for follow up.
Exclusion Criteria
* Known immunodeficiency.
* Known allergy to fibrin glue or one of its components.
* An undrained perianal abscess, diagnosed by a physical examination or imaging methods.
* Known Alcohol or drug abuse
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ResQ Medical Ltd
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ResQ Medical Ltd
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eran MR Goldin, Prof
Role: PRINCIPAL_INVESTIGATOR
Hadassah Medical Organization
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hadassah medical center
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Eran Mr Goldin, Prof
Role: CONTACT
Phone: 02-6776848
Haim Mr Halevi, Dr.
Role: CONTACT
Phone: 052-2479211
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Eran Mr Goldin, Prof
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H.K.prot.02-03-08
Identifier Type: -
Identifier Source: org_study_id